ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentZurichInthera Bioscience AG
Inthera Bioscience AG Logo
Verified· 4 sourcesTrust Score
Summary

About the company

The core activity of Inthera Bioscience AG is the development of therapies for previously incurable types of cancer, particularly through the selective destruction of cancer cells by replicative stress. The company covers the entire value creation process, from target discovery and validation to early drug development, medicinal chemistry, preclinical and toxicological work, as well as early clinical development.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
3.6/5

Inthera Bioscience AG

✓ Offered2
Oncology API research and development
API research and preclinical development against cancer, focusing on target identification, validation, early drug discovery, medicinal chemistry and early clinical development.
Development of INTH-454
Development of the synthetic small molecule INTH-454 that inhibits tumor cell growth and triggers cell death, with preclinical efficacy and IND-enabling clinical progression.
Trust & reputation

ranQ Trust Score of Inthera Bioscience AG: 3.6 out of 5.0

Trust Score3.6/ 5.0

Solid

x

Data basis 100% · As of October 2026

Inthera Bioscience AG scores 38.7 out of 100 points in the Reputation area of the ranQ Trust Score. This area carries 42% of the weighting.
x
CriterionValueWeight
  • Review quality: The average rating across all connected sources, smoothed against the industry mean. So 5.0 stars from three reviews do not outrank 4.7 from three hundred.0.024%
  • Review volume: The number of reviews across all sources. The scale is logarithmic: the first reviews count the most, and the maximum is reached at 50 reviews.100.010%
  • Review recency: The age of the most recent review. Two-year-old reviews deliberately sit in the middle, because that is normal for Swiss SMEs. Only after three years without a new voice does the value drop markedly.78.08%
Inthera Bioscience AG scores 87.2 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.95.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
Inthera Bioscience AG scores 86.7 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).86.722%
Inthera Bioscience AG scores 17.9 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.25.74%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.10.04%
Qualifications+0.00

Inthera Bioscience AG reaches a ranQ Trust Score of 3.6 out of 5.0 — rated «Solid». The rating draws, among other things, on 1.0 out of 5 stars from 233 customer reviews. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Reviews

Aggregated rating

Aggregated rating
1
of 5

Aggregated from 233 reviews across all connected sources

Sources
GGoogle1233
★TrustpilotSoon
PProvenExpertSoon

Further sources are added continuously and factored into the ranQ Rating.

Press

Media

June 2, 2017Media
Inthera Bioscience Raises CHF 10.5 Million in Series A Financing Round
startupticker.ch

Knowledge

No knowledge articles yet

Once Inthera Bioscience AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Inthera Bioscience AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Inthera Bioscience AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Inthera Bioscience AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Oleanderstrasse 14
8050 Zurich

At a glance

Legal form
Corporation
UID
CHE-412.998.242
Founded
2013 · 13 years
Last commercial register change
December 30, 2024
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    ST
    Steinbeis Transfer AG
    Zurich
    EA
    EVIIVE AG
    Obfelden
    NM
    NanoFLOWCELL Management AG
    Kilchberg Zh
    EE
    Eagle Eye Solutions GmbH
    Meilen
    GA
    Grow Art AG
    Turbenthal
    KI
    klb innovation GmbH
    Wädenswil
    HA
    Hesstech AG
    Bubikon
    OP
    Otsuka Pharmaceutical (Switzerland) GmbH
    Glattbrugg